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ILCs burst onto the immunological scene with their involvement in bacterial and helminth
infections. As their influence has emerged, it has become clear that they play a
fundamental role in regulating barrier tissue homeostasis and the immune response
during inflammation. A subset of ILCs, ILC2s, has become the focus of attention for many
helminth biologists—stepping into the limelight as both the elusive initiator and amplifier
of the type-2 response. In many of the early reports, conclusions as to their function
were based on experiments using unadapted parasites or immune-compromised hosts.
In this review we re-examine the generation and function of type-2 ILCs in helminth
infection and the extent to which their roles may be essential or redundant, in both
primary and challenge infections. ILC2s will be discussed in terms of a broader innate
network, which when in dialogue with adaptive immunity, allows the generation of the
anti-parasite response. Finally, we will review how helminths manipulate ILC2 populations
to benefit their survival, as well as dampen systemic inflammation in the host, and how
this understanding may be used to improve strategies to control disease.
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INTRODUCTION
Parasitic helminth infections by tapeworms, roundworms or flukes present an ongoing threat to
human health and quality of life, but also significantly dampen agricultural productivity through
infection of livestock.Worldwide, over 2 billion people are infected with helminth parasites (1), and
in the absence of any vaccines, control relies on repeated drug treatment. Understanding immunity
to helminths is essential to develop new vaccines to eliminate these infections.
Until about a decade ago it was suggested that resistance to helminth infection relies
predominantly on T helper 2 (Th2) cells of the adaptive immune system, orchestrating nematode
expulsion in an antigen-specific manner. Since then a new player has entered the game, the type-2
innate lymphoid cells (ILC2), first discovered in T- and B-cell-deficient mice as a subset rapidly
releasing type-2 cytokines, in response to stimulation by the alarmin IL-25 (2, 3).
Thereafter, convergent approaches, including functional testing of new IL-17 family members
(3–5), determining innate sources of type-2 cytokines (6–8) and the characterization of mesenteric
lymphoid clusters (9), all led to the identification of an innate lymphocyte population, capable of
producing type-2 cytokines, albeit with varied monikers such as “nuocytes” (6) or “natural helper
cells” (9). Soon re-branded as ILC2s, these innate cells were found localized to differing tissues and
therefore primed to act as first responders to the immune challenges such as helminth infections
before adaptive immunity has developed (10).
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Since the discovery of these innate Th2 cell surrogates,
research delineating ILC2 functions, especially in the disease
settings of helminth infection and allergic asthma, have
dominated the scientific field of type-2 immunity. Wide-ranging
studies have reported on the cells’ origin and differentiation,
plasticity, mobility, functionality and communication with
various other cells of the immune system, and beyond (11,
12). Much has been learned from mouse models of intestinal
helminth infection, in particular Nippostrongylus brasiliensis, a
rat parasite which is poorly adapted (and thus readily dislodged)
from mice, and 2 natural parasites of mice, Heligmosomoides
polygyrus and Trichuris muris (Figure 1). ILC2s are also
stimulated by helminths in the tissues, such as Litomosoides
sigmodontis in the pleural cavity (13) and by the eggs of
Schistosoma mansoni in the liver and lungs (14).
GENERATION AND REGULATION OF
ILC2 ACTIVATION
In mice, the development of both ILC2s and Th2 cells starts
with common lymphoid progenitors (CLPs) of the bone marrow
(15, 16), but branches in two different directions. In fact, the
development of all T lymphocytes begins with the differentiation
of lymphoblasts from CLPs, their migration to the thymus, then
if surviving both positive- and negative selection, they emerge as
highly specific but antigen-naïve immune cells patrolling through
the circulation, secondary lymphoid tissue and peripheral sites.
Importantly, T cells only polarize into functional Th2 effector
cells following specific antigen encounter in the presence of
interleukin 4 (IL-4) (17).
In contrast, the development of ILC2s is rather primitive.
CLPs give rise to common innate lymphoid progenitors (CILPs)
dependent on the expression of various transcription factors,
amongst others inhibitor of DNA binding 2 (Id2) and nuclear
factor IL-3 induced (Nfil3) (9, 18, 19). Yang et al suggest that
early innate lymphoid cell progenitors (EILPs) resemble an
intermediate step in the differentiation of CLPs into CILPs. The
development of this T cell factor-1 (TCF-1) positive population
is still independent of Id2 and EILPs are progeny of both NK
cells and ILCs (20). CILPs give rise to common helper innate
lymphoid progenitors (CHILP) which differentiate based on
promyelocytic leukemia zinc finger (Plzf) expression into ILC
precursors (ILCPs) (21), able to polarize into three different
innate lymphoid cell populations, ILC1s via expression of
Tbx21/T-bet (22, 23), GATA3 positive ILC2s (15, 24) or, based
on Rorγt expression, ILC3s (25, 26).
This broad classification of 3 ILC subsets may hide important
distinctions within, for example, ILC2s which have been divided
into natural and inflammatory, responsive to different cytokines
(27), or between cells of similar cytokine profiles but different
tissue residence, location or preference for skin, lung, or gut
(28). ILC2s are mainly regarded as tissue–resident, expanding
upon helminth infection at the respective mucosal site (29). This
model has been challenged recently in a study demonstrating the
migratory capabilities of IL-25-induced “inflammatory ILC2s”
of the intestine (30, 31). These, when activated by IL-25, were
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FIGURE 1 | Schematic time-lines for parasite burdens and ILC2 responses for
(i) N. brasiliensis, (ii) H. polygyrus, and (iii) T. muris. Red lines indicate parasite
burdens (larval/adult numbers, egg production); black lines indicate ILC2
activity (proliferation, cytokine release). Location and timing of different parasite
stages are indicated where appropriate. For N. brasiliensis and H. polygyrus,
both primary and secondary infections are shown; primary N. brasiliensis
infections are expelled naturally, while for H. polygyrus anthelmintic drug
treatment is required in susceptible strains to clear the primary infection prior
to a challenge re-infection. For H. polygyrus and T. muris, separate lines
indicate genetically resistant and susceptible strains of mice.
found to enter the lymphatics and transfer to the lung where they
contribute to the anti-helminth response. Controversy also arises
over whether these ILC subsets are committed lineages, or show
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plasticity akin to their adaptive T cell cousins; while commitment
would represent “trained immunity” in which the innate immune
system is more prepared for subsequent encounters with the
same pathogen, it might lock the innate response into an
inappropriate and potentially pathogenic program that is difficult
for the host to reverse.
HELMINTHS AND ILC2s—ANCIENT
ANTAGONISTS?
ILC2s and Th2 cells share common attributes, but they also differ
in the complexity of their development, the rules governing their
tissue tropism, and the specificity of immune stimuli to which
they respond (30). This poses the question of whether the more
complex and target-specific Th2 cells developed evolutionarily
from ILC2s, or if both type-2 immune cell populations share
vertical descent from one ancestral population. The first would
imply that ILC2s emerged prior to Th2 cells, potentially
as an elementary cell type to combat helminth infection in
ancient hosts.
To shed light on the evolutionary development of the three
different ILC populations, including ILC2s, Vivier et al analyzed
comparative expression of critical genes in different vertebrate
species from the lamprey to mammals (32). Notably, a significant
part of the ILC progenitor gene profile, including Id2, Nfil3 and
Gata3, as well as parts of the ILC2 profile, including Ptpn13, Ar,
Rxrg, Ccr8, and Hs3st1 are already evident in jawless vertebrates,
whereas the Gata3-controlled type-2 cytokine genes, Il5 and Il13,
crucial for ILC2 and Th2 cell effector functions in mice and
humans, were exclusively found in birds and mammals (32).
This initial study certainly suggests that ILC2s emerged in
evolution of the earliest agnathan vertebrates, in response to
helminth parasites. Even today, sea lamprey intestines contain
a variety of nematode species, ingested while feeding on fish
(33). A different perspective on the evolutionary development
comes from a phylogenetic analysis of genes crucial for ILC2
activation in mammals. Here it has been highlighted that
lampreys do express IL-17 family orthologs, amongst them IL-25
(34). Orthologs of the crucial receptor heterodimer subunit IL-
17RB for IL-25 signaling in humans andmice however, have been
detected only from the emergence of cartilaginous fish onwards
and have not been found in jawless fish (34).
Phylogenetic analyses of genes involved in the differentiation
of different immune cell populations suggest that ILC2s, as
T-cells, developed in ancient mammalian ancestors. Substantial
differences in the differentiation of both cell types certainly
suggest that their relationship is distinct and that ILC2s
are closely related to the other ILC subtypes. A different
perspective might be provided through comparisons of
genome-wide chromatin accessibility of both populations
during helminth infection (35). Hierarchical clustering of
these regulatory ensembles—termed “regulomes” within
Th2 cells and ILC2s isolated from lungs at day 10 post N.
brasiliensis infection confirmed the difference between pre-
established ILC2s and naïve CD4T cells. Regulomes of both
cells during infection showed high similarity, not discounting
a potential close relationship between both cell types during
evolution and more ancient ILC ancestor that has preceded Th2
cells (35).
This perspective is further supported by the aforementioned
study on the migration of activated iILC2s, highlighting that
both T cells and iILC2s share the capability to migrate along
a sphingosine-1-phosphate (S1P) gradient, a mechanism crucial
for effector T cells to leave lymphoid tissues and essential for
iILC2s to enter the lymphatics from the intestine (31). The report
extends the parallelism of both type-2 cell types beyond the
level of genomics and immune effector functions not excluding
that the S1P trafficking mechanism of T cells was adopted from
ancient ILCs (30).
ALARMIN ACTIVATION OF ILC2s—THE
ROLE OF IL-25
As discussed above, ILC2 development requires the transcription
factor GATA3 (24) and the nuclear receptor RORα (15,
36). Once differentiated, ILC2s are highly responsive to the
alarmins, IL-25, IL-33 and TSLP, binding, respectively to
the heterodimeric receptors IL17RA/IL17RB, ST2/IL1RacP, and
TSLPR(CRLF2)/IL7Rα (37), while also requiring signaling
through the common cytokine receptor γ chain (γc) that is shared
by IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21 (9).
IL-25 is closely linked, in presence and function, with
helminth infections, and was first characterized by elevated
expression in the small intestine following N. brasiliensis
infection, leading to IL-5 production by the then unnamed ILC2s
(3). IL-25−/− mice were then shown to be unable to expel T.
muris, while genetically susceptible mice given exogenous IL-
25 became resistant to infection (38). Similarly, IL-25−/− mice
were used to demonstrate that IL-25-dependent activation of
ILC2s is required for protective immunity to N. brasiliensis
infection (4). Moreover, it was demonstrated that transfer of IL-
25-stimulated ILCs could mediate expulsion of N. brasiliensis in
mouse strains lacking key type-2 components, such as IL-13, IL-
25, or IL-33 (6). In particular, while exogenous IL-25 induced
worm clearance in RAG-deficient mice (31), it did not do so in
animals lacking both adaptive immunity and ILCs (Rag-2−/− x
γ
−/−
c mice) (7). This latter study also demonstrated that transfer
of ILCs alone was not able to induce worm clearance in Rag-
2−/− x γ−/−c mice unless exogenous IL-25 was administered to
recipient animals.
Subsequently, IL-25 has been shown to activate a variety of
innate cells, including multi-potent progenitor type-2 cells (39),
NKT cells (40, 41) as well as monocytes and eosinophils (42).
Within the ILC2 population, it has been proposed that one subset
of “inflammatory ILC2s” (iILC2s) preferentially express the IL-
25 receptor, and not the IL-33 receptor ST2 (27). Inflammatory
ILC2s arise early inN. brasiliensis infection and give rise to IL-33-
responsive “natural ILC2s” for worm expulsion, although it was
also found that iILC2s, co-expressing GATA3, and RORγt, have
the capacity to switch to IL-17 producing ILC3s in the different
setting of fungal infection (27).
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Recently, it was discovered that epithelial tuft cells of the small
intestine detect the presence of helminths and release IL-25 (43–
45), resulting in ILC2 proliferation (44) (Figure 2A). While the
helminth derived mediator responsible for activating the tuft cell
signaling cascade is still unknown, it is clear that protozoans
are capable to induce tuft cells and successively ILC2 activation,
through the release of succinate and stimulation of the succinate
receptor GPR91 (46, 47). The activation of intestinal ILC2s by IL-
25 is negatively regulated by the deubiquitinase A20 (Tnfaip3),
which binds and inhibits the IL-25 receptor subunit IL-17RA
(48). During infection with N. brasiliensis, A20 expression in
ILC2s is downregulated, allowing increased pathogen-induced
ILC2 proliferation (49).
While two other key alarmin cytokines, IL-33, discussed
below, and thymic stromal lymphopoietin (TSLP) are able
to induce ILC2 expansion, the responsiveness to these differs
between ILC2 populations located at various mucosal sites.
Small intestinal ILC2s express elevated levels of IL-17RB and
are therefore responsive to tuft cell-derived IL-25, whereas
pulmonary and adipose tissue ILC2s express high levels
of ST2, resulting in increased IL-33 sensitivity (50). While
not essential for ILC differentiation, TSLP is particularly
important for activating ILC2s in the skin, for example in
models of atopic dermatitis, which is abated in Tslpr−/−
mice (51) and is also required for immunity to T. muris
in the intestinal tract (52). However, TSLP also activates
dendritic cells to promote adaptive Th2 responses (53),
and acts on other innate populations such as basophils
(54), so that it promotes type 2 responses at multiple and
complementary levels.
IL-33, KEY PLAYER FOR ILC2s
IL-33, an IL-1-like cytokine that potently activates the type-2
response, is released from damaged epithelial cells (Figure 2B),
and from innate subsets such as mast cells responding to
damage signals from their environment (55–57). The role
of IL-33 in ILC2 activation has been explored intensively
by utilizing murine helminth models with pulmonary life
cycle stages, including N. brasiliensis and the threadworm
Strongyloides venezuelensis. Both induce a significant increase
in lung/airway IL-33, IL-33 dependent ILC2 activation, type-
2 cytokine release and eosinophilia (6, 7, 9, 58, 59). IL-
33-deficient mice show a significantly elevated intestinal
N. brasiliensis worm burden at day 6 p.i. and increased
fecal egg counts at day 8 post S. venezuelensis infection,
underlining a contribution of IL-33 activated ILC2s to the
clearance of these nematodes (58, 59). Mice lacking the IL-
33-specific receptor subunit ST2 are also highly susceptible
to H. polygyrus infection (60), in addition, exogenous IL-
33 confers resistance on mice genetically susceptible to T.
muris (61).
As deficiency in either IL-25 or IL-33 results in greatly
enhanced susceptibility to helminth infection, these alarmins
are not generally redundant. However, it is possible to
circumvent the lack of one alarmin with cell populations
strongly activated by another. Thus, transfer of ILC2s
cultured in the presence of IL-7 and IL-33 restored expulsion
of N. brasiliensis in mice lacking the receptor for IL-25
(Il17rb−/−) (6). Moreover, the same authors reported that
transfer of IL-13-expressing ILCs was sufficient to induce
expulsion in mice lacking both receptors for IL-25 and IL33
(Il17rb/Il1rl1−/−) or type-2 cytokines (Il-4/Il-13−/−). Here,
as discussed below, the ability of ILC2s to mediate worm
expulsion was dependent on dialogue with the adaptive immune
system and generation of antigen-specific T cell production
of IL-13.
ILC2s—OTHER SIGNALS, SMALL
AND LARGE
A range of small molecules are also able to orchestrate ILC2
functions, including arachadonic acid-derived eicosanoid (20-
carbon) lipids. Human ILC2s can be activated by prostaglandin
D2 through the CRTH2 (DP2) receptor (Figure 2C) (62) and
their cytokine production can be further enhanced by stimulation
with leukotriene E4 (63). In mice, leukotrienes can sufficiently
induce type-2 cytokine production by ILC2s, with leukotrienes
C4 and D4 being most efficient in provoking this response,
whereas stimulation with leukotriene B4 and E4 only resulted
in marginal IL-13 production (Figure 2C) (64, 65). In particular,
leukotriene D4 drives IL-4 production by ILCs (66, 67). The role
of eicosanoid mediators in nematode infection was investigated
using gene-deficient mice of the respective leukotriene receptors
or synthases, highlighting that deficiency in the LTB4 high
affinity receptor Ltb4r1 did not affect ILC2 activation in the
lungs of N. brasiliensis infected mice. Activation was reduced
by Cystlt1r (LTD4/LTC4 receptor) or Ltc4s (LTC4 synthase)
deletion and abrogation of ILC2 activation was achieved in
mice lacking Alox5 (5 lipoxygenase, which catalyses the initial
step of leukotriene synthesis) or the combination of Ltb4r1
and Ltc4s (65). Inhibitory properties with regards to ILC2
activation were reported for lipoxin A4 (Figure 2C) (68) and
prostaglandin E2 for human (69) and prostaglandin I2 for mouse
(70) ILC2 cells.
Recent studies have highlighted the sensitivity of ILC2s to
dietary vitamin A deficiency (71) and related their function to
a requirement for fatty acids, acquired from the environment
(72). In the event of vitamin A deficiency, the subsequent
absence of retinoic acid resulted in the predominance of ILC2s
in the small intestine and an increased resistance to T. muris
infection (Figure 2A) (71). Under these conditions, ILC2s in
the mesenteric adipose tissue increased their acquisition of
long-chain fatty acids and raised production of IL-5 and IL-
13 (72). Thus, as a result of nutrient deprivation, enhanced
ILC2 activity is allowed ensuring that helminths are discharged
more efficiently.
More recently, the A2B adenosine receptor was found
to promote ILC2 activation and type-2 cytokine expression,
controlling the primary and secondary immune response to H.
polygyrus infection and the primary immune response to N.
brasiliensis infection (73). This study also revealed adenosine as a
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FIGURE 2 | ILC2s are embedded into a multifaceted network of barrier- and neuro-immune responses. (A) Luminal & epithelial crosstalk. Intestinal nematodes are
detected by tuft cells of the small intestinal epithelium. While the helminth-derived mediator activating tuft cells is unknown, these chemosensory cells release IL-25,
activating the IL-25 receptor (IL17RA/IL17RB) on ILC2s. ILC2s are negatively regulated by the vitamin A metabolite retinoic acid, signaling through retinoic acid
receptors. (B) Alarmins & inhibitors. In addition to IL-25, ILC2s are induced by IL-33, an alarmin located inside the nuclei of epithelial cells. Upon damage to the
epithelial lining, IL-33 is released. The nematode-derived alarmin inhibitor HpARI is able to sequester IL-33 inside the nuclei of damaged cells, attenuating the
IL-33-induced ILC2 activation. (C) Eicosanoid signaling. Additionally, ILC2s are activated by various eicosanoids, including PGD2 and leukotrienes, activating the
respective receptors, while negative regulation of ILC2s has been documented for lipoxin A4. (D) Neuro-immune interface. ILC2s are essential for the communication
between enteric neurons and the epithelial barrier. NMU, released by neurons during helminth infections activates ILC2s via NMUR1 potentiating the epithelial response
initiated to discharge the intruders. ILC2s are also stimulated by VIP, but VIP release by neurons during helminth infection has not been documented as of yet.
novel danger-associated molecular pattern (DAMP), responsible
for initiating helminth-induced type-2 responses, through
activation of ILC2s.
Additional receptors reported to be highly expressed by ILC2s
and required for their expansion and function include the
tumor necrosis factor (TNF)-receptor superfamily member DR3
(TNFRSF25) and the IL-9R. In the absence of TL1A ligation
to DR3, there is significantly reduced ILC2 expansion, type-2
cytokine production and N. brasiliensis expulsion (74), whereas
IL-9R signaling was required for ILC2 accumulation, expulsion
of N. brasiliensis and resolution of tissue damage in the lung (75).
IL-4- and IL-13-dependent expression of the acidic mammalian
chitinase (AMCase) was also found to promote ILC2 expansion
in the lung and expulsion of both N. brasiliensis and H. polygyrus
from the gut (76).
Recently, the capacity of ILC2s to migrate between
mucosal sites has become recognized with the experimental
demonstration of a S1P-dependent pathway leading ILCs from
the gut to the lung (30). MLN and lung iILC2s express S1P
receptors and FTY720 inhibition of this pathway blocked
the accumulation of intestinal iILC2s in the lung. When
administered to Rag1−/− mice, FTY720 induced a significant
increase in mortality to N. brasiliensis infection, which in turn
can be prevented by an intravenous adoptive transfer of iILC2s
prior to FTY720 administration (31). The role of chemokines
in ILC2 migration and trafficking is understudied, though gene
expression studies show that in comparison to other NK-cell and
ILC subsets, small intestinal ILC2s express enhanced levels of
Cxcr6 and Ccr4, 8, and 9, while also producing attenuated levels
of the chemokine ligand Ccl1 (77). Additionally, ILC2s express
a number of surface receptors regulating cell-cell interactions.
ILC2s express KLRG1, which as shown using human skin
ILC2s, can interact with E-cadherin and dampen ILC2 specific
type-2 cytokine expression (78). ILC2s also display ligands
for OX40 and ICOS that mediate interactions with T cells as
discussed below.
ILC2s at the Neuro-Immune Interface
Most recently, emphasis has been placed on delineating ILC2
function in the neuro-immune network during helminth
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infection. ILC2s are located in close proximity to enteric neurons,
primed to receive neuronal signals during infection. ILC2s were
found to selectively express Neuromedin U receptor 1 (Nmur1),
whereas mucosal neurons expressed the small neuropeptide
neuromedin U (Nmu) (79, 80). Following infection with N.
brasiliensis, Nmu expression was increased in both the lung
and the gut, resulting in robust ILC2 responses through Nmur1
and worm clearance (Figure 2D); in contrast, if adoptively
transferred intoRag2 Il2rg deficientmice,Nmur1 (NMU receptor
1) deficient ILC2s produce significantly reduced amounts of
type-2 cytokine than their gene sufficient counterparts (79,
80). ILC2s are also activated by the neuropeptides vasoactive
intestinal peptide (VIP) (81) (Figure 2D) and calcitonin gene-
related peptide (CGRP) (82), although as yet it is unclear if these
neuronal effectors play a significant role in ILC2 activation during
helminth infection.
Interestingly, ILC2 activity was reported to be negatively
regulated by acetylcholine through the nicotinic acetylcholine
receptor α7nAChR (83), catecholamines (e.g., epinephrine)
ligating the β2-adrenergic receptor (84), as well as the aryl
hydrocarbon receptor (AhR) although in the latter case
this may operate through preferential expansion of ILC3
cells (85).
DIALOGUE WITH ADAPTIVE IMMUNITY
An important early finding in the field was that ILCs did not
prosper when transferred to RAG-deficient animals, and indeed
ILC2 transfer did not succeed in conferring immunity to N.
brasiliensis to this genotype (6). It is now well appreciated
that ILC2s closely communicate with the adaptive immune
system, allowing for the initiation and amplification of a
robust type-2 response (86). For example, ILC2s promote Th2
immunity by enhancing CD4+ T cell function through MHCII
expression (87, 88). In the setting of helminth infection, ILC2s
express high levels of surface MHC class II, as well as IL-
25R (IL-17RB), and drive Th2 and Th9-mediated clearance of
Trichinella spiralis (89). ILC2 “help” for Th2 cell differentiation
may require IL-4, as mice lacking this gene only in the
ILC compartment show attenuated Th2 cytokine production
following H. polygyrus infection, although no increase in
susceptibility was reported (67).
ILC2s have also been shown to upregulate expression of
the checkpoint inhibitor PD-L1, following infection with N.
brasiliensis. Surprisingly, expression of this molecule by ILC2s
promoted production of IL-13 by Th2 cells and enhanced
expulsion of the gastrointestinal nematode (90). Interestingly,
ILC2s were also reported to promote regulatory T-cell expansion
following N. brasiliensis infection. This interaction was suggested
to be reliant on the expression of ICOSL by ILC2s and
ICOS by Tregs (91). In the context of helminth infection
with N. brasiliensis, lung ILC2s express OX40L in response
to IL-33 stimulation allowing enhanced communication with
OX40+ T-cells (92). ILC-specific OX40L deficient Il7r(Cre)
Tnfsf4(fl/fl) mice display a suppressed adaptive type-2 immune
profile at d28 p.i., with significantly decreased numbers of
both GATA3± Tregs and GATA3+ Th2 cells, together with
a mildly elevated intestinal worm burden at day 5 p.i. (92).
Finally, in addition to ICOSL, ILC2s express ICOS, which can
act as an inhibitory receptor in interactions with regulatory T
cells (93).
ILC2s IN HELMINTH
INFECTIONS—SUFFICIENCY, NECESSITY,
OR REDUNDANCY?
The immune system has evolved multiple protection
mechanisms against helminth infection, and the literature
has documented a range of cell types, which if suitably activated
and expanded, can mediate helminth expulsion (94, 95). For
reasons discussed above, elimination of N. brasiliensis may be
achieved more readily by multiple mechanisms, providing a
sensitive test-bed for immunity to helminths. In this system, the
principle has been established that innate sources of IL-4/IL-13
are sufficient for expulsion in animals unable to produce these
cytokines within the T cell population (96). Consistent with
this, adoptive transfer of ILC2s (6) induces nematode expulsion.
However, transgenic mice with chronic eosinophilia [through
IL-5 over-expression (97)] are also resistant to infection. The
demonstration that disparate cell types are individually sufficient
to combat helminth infection in mouse models is consonant
with other studies showing that few are essential; demonstrating
considerable redundancy.
In mouse models other than N. brasiliensis, with parasite
species naturally adapted to the mouse, adoptive cell transfer
of ILC2s has not been quite so effective, inducing partial, but
not complete, clearance of T. muris (5) and H. polygyrus (67).
In the case of H. polygyrus, Hepworth and colleagues (98)
reported “negligible” MLN ILC2 numbers (0.2 × 105 cells) at
day 6 of infection of C57BL/6 mice, requiring exogenous IL-
25 treatment to boost the number of MLN ILC2 cells to reach
levels observed during N. brasiliensis infection (H. polygyrus: 3
× 105 cells vs. N. brasiliensis: 5 × 105 at d5 p.i.) (99). This
may reflect the poor responsiveness of this strain, as ILC2
responses are greater in more resistant mouse strains such as
BALB/c and SJL (100) (Figure 1B). However, the theme of
multiple pathways to resistance recurs with H. polygyrus, as both
transfer of M2 macrophages (101) or transgenic amplification of
mast cells (resulting in higher ILC2 levels) (57) are protective
against infection.
ILC2-mediated immunity to N. brasiliensis infection can also
be driven by other helminths, such as S. venezuelensis, which
evokes a sufficiently strong expansion of ILCs in the lung, that
a subsequent N. brasiliensis infection is significantly reduced
in both worm number and egg output (102). Consistent with
other information on the lung environment, the ILC2 response
at this site required IL-33. Perhaps this finding recalls an ancient
evolutionary role of ILCs in providing early chordates with
generic protection against helminth infection, as discussed above.
An important point of consideration is that ILC2s are not
the sole target of IL-25 activation in helminth infection, given
evidence that other innate cell types such as monocytes (101),
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other myeloid cells (103) and NKT cells are responsive to this
cytokine. In addition, IL-25 promotes progenitor cells [mpp-
type2, (5)], which can differentiate into mast cells. Many of these
cell types are thought to be involved in immunity to helminth
infection. Indeed, utilizing the H. polygyrus model of nematode
infection, we were able to show that worm expulsion could be
induced by IL-4 and IL-25 in RAG-deficient mice, and that this
process was unimpeded by depletion of CD90+ ILCs prior to
cytokine administration (42). Hence in these more tenacious
helminth infections, ILC2s may not be sufficient for immunity,
and indeed may even be redundant.
ILCs IN HUMANS
While these studies extended our appreciation of ILC2s across
a considerable number of helminth infections in mice, less
information is available on their involvement in human helminth
infections (104, 105). The theme of redundancy is echoed
in human studies, as individuals lacking ILCs (following
hematopoietic stem cell transplantation therapy) appear to
lead healthy lives for many years (106, 107), although these
patients are not likely to have been exposed to helminth
parasite infections.
As highlighted by Nausch and Mutapi, many helminth
parasites invade through, or establish a niche in, the skin
of their host, and consequently are likely to encounter
skin ILC2 cells (105). Parasites also frequently interact with
mucosal sites, in particular the gastrointestinal tract, where
ILC2s may be activated. Due to inaccessibility of these tissues
in infected patients, studies delineating the immunology of
human nematode infections are mostly reduced to analyses of
peripheral blood, in which ILC2s may represent < 0.05% of
live blood leucocytes (105). Nonetheless, helminths do cause
changes in peripheral blood ILC populations. In a patient
cohort of Zimbabwean children infected with S. haematobium,
significantly fewer circulating ILCs were found in 6–13 years-
olds, but normal levels observed in Schistosome-specific antibody
positive infected children older than 14 years (108). Thus, there
is an age-specific effect, which speaks to the increased relevance
of ILC2s during early life before immunity is dominated
by a mature adaptive immune response. In a second study,
blood was taken from adult patients infected with the filarial
nematodes Loa loa, O. volvulus, and Wuchereria bancrofti, and
ILC2s and ILC3s were analyzed together as CD127+CD117+
cells (13). These authors reported increased blood ILCs in
these infections, contrasting with the observations made of
S. haematobium infection, highlighting that the ILC response
might be heterogeneous in different infection settings and
age groups.
The inaccessibility of ILC2s in the key tissues of humans
returns the focus to events induced by human parasites in
mouse models of helminth infection. Initial studies highlight an
upregulation of key ILC2- inducing alarmin genes Il1a, Il1b, Il33,
and Tslp shortly (6 h) after percutaneous S. mansoni cercariae
infection of the pinna (109). Further, a study of combined IL-
25, IL-33, and TSLP cytokine targeting during chronic murine
S. mansoni infection revealed that ablation of either or both IL-
25 and IL-33 is not sufficient to significantly alter S. mansoni-
induced type-2 pathology in both the lung and the liver (110).
Indeed it was needed to target all 3 alarmins utilizing IL-
33−/− x TSLP−/− mice administered anti-IL-25 from week 4
to significantly reduce the liver granuloma volume at week 9,
concomitant with a reduced granuloma eosinophil percentage
and attenuated MLN IL13+ ILC2 levels. However, by week 12
alarmin neutralization did not alter type-2 pathology, and Th2
cytokines had actually increased (110), again underlining that
ILC2 effector functions may be restricted to the acute phase
of type-2 immunity and that loss of ILC2 function can be
compensated for by accelerated activity of Th2 cells.
CAN HELMINTHS MANIPULATE
ILC2 FUNCTION?
Helminth infections can clearly stimulate type-2 responses yet
have the ability to modify them, as part of their immune evasion
strategy. An obvious immune cell candidate for targeting in order
to avoid effective immunity is the ILC2. Following infection with
the chronic helminth parasite H. polygyrus, there is a limited
expansion of ILC2s in the mesenteric lymph nodes (MLN) (42,
98, 100). Indeed, a recent study revealed preferential trafficking of
LTi-like ILC3s to theMLN followingH. polygyrus infection (111).
Infection with this chronic gastrointestinal nematode has been
shown to promote the release of host-derived IL-1β, which limits
IL-25 production and the subsequent activation of ILC2s (112).
Further evidence of the ability of H. polygyrus in adapting to
the hosts’ capacity to drive ILC2 activation via alarmin cytokines
was recently revealed by the discovery of the IL-33 inhibitor
HpARI, which is released by the helminth and sequesters IL-33
in the tissue (Figure 2B) (113). In addition, the same parasite
releases extracellular vesicles that target expression of ST2, the
IL-33 receptor, and are able to dampen the ILC2 response to
Alternaria alternata fungal allergen challenge in vivo (114). Many
helminths, H. polygyrus included, further modulate the adaptive
immune system by promoting regulatory population such as
regulatory T cells (115); with the recent description of IL-10-
producing regulatory ILCs (116), it will be interesting to establish
if some parasite species can dampen host immunity through
immunosuppressive cells of the innate, as well as the adaptive,
immune system.
CONCLUSION
ILC2s are clearly an inherent feature of the immune response to
helminth infection, and in all probability their evolution has been
driven by the threat of parasites. While in experimental model
systems they are not always found to be essential, they are often
center stage, particularly in the early phases of infection of each
helminth system so far analyzed. They also form an important
conceptual and mechanistic link with the allergic response that
will allow us to understand in more detail the genesis and control
of allergic disorders. In this respect, a much fuller analysis of
ILC biology and function in the human type 2 response, both in
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helminth infections and allergy, is eagerly awaited. Finally, the
question remains to be answered of whether we can design new
interventions, ideally vaccines, which take advantage of the ILC2
phenotype to promote protective immunity against helminth
parasites and to control and remove the enormous burden of
worm infections across the world.
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